SOURCE: Telzuit Medical Technologies, Inc.

May 31, 2007 12:18 ET

Telzuit Medical Technologies: New Phase in the Company's Life Cycle -- STATPATCH System Sales Begin

ORLANDO, FL--(Marketwire - May 31, 2007) - Telzuit Medical Technologies, Inc. (OTCBB: TZMT)

--  Yesterday, Telzuit began selling the STATPATCH System through its
    distribution partner American Radiologist Network (Amrad) to nursing home
    patients in North Carolina.
    
--  Amrad expects to roll out the product to its 250+ nursing home clients
    in North Carolina over the next several months and then the parties hope to
    expand the relationship to other states where Amrad provides services.
    
--  New Line Medical has begun to take orders for delivery of the PDA
    version of the product.
    

Yesterday, May 30, 2007, the management teams of Telzuit and Amrad were on hand in North Carolina to begin the roll out of the product to nursing homes and assisted living facilities in North Carolina. Amrad took delivery of the patches and has begun to roll out the product. Use of the STATPATCH System by Amrad's affiliate to its clients is about to begin. We expect to generate billable events in June.

Telzuit's distributor, New Line Medical, has begun pre-marketing the product in the seven states where it does business and has begun to sign up physician practices which will begin to use the product later in June.

Warren Stowell, CEO of Telzuit, commented that "Our Company has entered a new phase in its life cycle. We have begun the sales process. The early response from potential users of the STATPATCH System has been excellent."

Telzuit is building inventory to accommodate sales. It is also in the process of signing up additional distributors to expand the territories where it will have a presence.

About Telzuit Medical Technologies, Inc.

Telzuit Medical Technologies, Inc. is dedicated to providing advanced mobile medicine to patients. The STATPATCH System is a full 12-lead, completely wireless Holter monitor. The STATPATCH System has been approved by the FDA under a 510-K filing. Telzuit also provides ultrasound medical imaging services to physicians in Central Florida through six mobile imaging units. Telzuit is based in Orlando. For more information about Telzuit, its business model and its products, please visit the Company's web site: http://www.telzuit.com

Forward-Looking Statements: Except for factual statements made herein, the information contained in this press release consists of forward-looking statements that involve risks and uncertainties, including the effect of changing economic conditions, competition within the health products industry, customer acceptance of products, and other risks and uncertainties. Such forward-looking statements are not guarantees of performance, and Telzuit results could differ materially from those contained in such statements. These forward-looking statements speak only as of the date of this release, and Telzuit undertakes no obligation to publicly update any forward-looking statements to reflect new information, events or circumstances after the date of this release.

Contact Information

  • Contact:

    Jerry Balter
    Chief Financial Officer
    Telzuit Medical Technologies, Inc
    407-354-1222